本文へ移動
cccskills
無料GitHub で公開

pdm-carbohydrate-intake

Guidance for clinicians managing pregnant individuals with preexisting diabetes mellitus (PDM) who are evaluating daily carbohydrate intake; consider a carbohydrate-restricted diet (<175 g/day) or usual diet (>175 g/day) based on patient factors. Trigger when assessing nutrition in pregnancy for PDM, especially when discussing glycemic targets, weight gain, or fetal growth concerns.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md3.0 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Carbohydrate intake guidance in pregnancy for preexisting diabetes

STEP 1 — Gather Information

Collect diabetes type (T1DM/T2DM), current carbohydrate intake, HbA1c or CGM metrics, pregnancy trimester, gestational weight gain, fetal growth measurements, comorbidities (obesity, hypertension), history of ketosis or hypoglycemia, folate status, patient preferences, cultural dietary habits, and ability to adhere to meal plans.

STEP 2 — Rule In / Rule Out

If the patient has a history of ketosis, hypoglycemia, or is in the first trimester with low folate intake (risk of neural tube defects), rule out a carbohydrate-restricted diet (<175 g/day) and proceed to usual diet (>175 g/day); otherwise, continue to classification.

STEP 3 — Classify or Stratify

Stratify by patient preference and glycemic goals: Prefer carbohydrate-restricted diet (<175 g/day) if seeking tighter postprandial control and able to maintain ≥95 g/day carbs; prefer usual diet (>175 g/day) if prioritizing fetal growth simplicity or experiencing nausea/vomiting.

STEP 4 — Decide

For carbohydrate-restricted choice: prescribe individualized meal plan targeting 130–170 g/day carbs, adjust insulin to prevent hypoglycemia, and monitor urine or blood ketones weekly. For usual diet choice: prescribe meal plan >175 g/day carbs with focus on complex carbohydrates, adjust insulin based on postprandial glucose, and monitor gestational weight gain.

Clinical Guardrails / Mimics / Pitfalls

Do not recommend <95 g/day carbohydrates due to increased neural tube defect risk; avoid ignoring individual variability in insulin sensitivity; do not overlook cultural food preferences that affect adherence; remember to adjust insulin when changing carbohydrate intake to prevent hypoglycemia or hyperglycemia; do not use carbohydrate restriction as sole therapy without glucose monitoring.

Concrete Clinical Example

A 32-year-old woman with T2DM at 12 weeks gestation, HbA1c 7.2%, baseline intake ~200 g/day carbs, no ketosis history, normal folate, desires lower carb to limit weight gain. After discussion, she chooses carbohydrate-restricted diet targeting 150 g/day carbs; meal plan provided, insulin reduced by 10%, weekly ketone checks negative, and postprandial glucose improved.

Source: Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline, Endocrine Society and European Society of Endocrinology, 2025, DOI: 10.1210/clinem/dgaf288

TODO: consider adding scripts/calc.py for the pdm-carbohydrate-intake calculator

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する